HIGHLIGHTS
- who: Pelagia G. Tsoutsou from the Division of, Department, Vaudois University Hospital Centre (CHUV), Lausanne, Switzerland have published the research work: Emerging Opportunities of Radiotherapy Combined With Immunotherapy in the Era of Breast Cancer Heterogeneity, in the Journal: (JOURNAL)
- what: The clinical relevance of BC heterogeneity when designing studies in the era of introduction of immunotherapy is pivotal.
SUMMARY
Natural selection results in the persistence of the less immunogenic clones, through the expression of immunosuppressive cytokines and growth factors, though a procedure known as "immunoediting," which progressively enriches tumor microenvironment by . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.